Investors

Event Details

Hepatitis Delta International Network (HDIN)

April 13, 2016

Dr. Cihan Yurdaydin: “Exploring optimal dosing of lonafarnib with ritonavir for the treatment of chronic delta hepatitis — results from the on-going LOWR HDV - 2 study.” Oral; 4:15-4:30 pm

Location

Barcelona, Spain,
United States